These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8639430)

  • 1. Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia.
    Kawaishi K; Kimura A; Katoh O; Sasaki A; Oguma N; Ihara A; Satow Y
    Br J Haematol; 1996 May; 93(2):367-74. PubMed ID: 8639430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of beta 2 integrins and L-selectin on CML cells after treatment with IFN-alpha and allo-bone marrow transplantation].
    Tong X; Luo S; Hong W
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):474-6. PubMed ID: 11235567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
    Lewis ID; Haylock DN; Moore S; To LB; Hughes TP
    Leukemia; 1997 Apr; 11(4):581-7. PubMed ID: 9096699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization.
    Kirk JA; Reems JA; Roecklein BA; Van Devanter DR; Bryant EM; Radich J; Edmands S; Lee A; Torok-Storb B
    Blood; 1995 Jul; 86(2):737-43. PubMed ID: 7541674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cells.
    De Fabritiis P; Dowding C; Bungey J; Chase A; Angus G; Szydlo R; Goldman JM
    Leuk Lymphoma; 1993 Sep; 11(1-2):51-61. PubMed ID: 7693107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
    Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
    Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line.
    Cornelissen JJ; Wognum AW; Ploemacher RE; Frassoni F; Wagemaker G; Hagemeijer A; Löwenberg B
    Leukemia; 1997 Jan; 11(1):126-33. PubMed ID: 9001428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay.
    Shinjo K; Takeshita A; Higuchi M; Ohnishi K; Ohno R
    Br J Haematol; 1997 Mar; 96(3):551-8. PubMed ID: 9054663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
    Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
    Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-selectin expression in CD34 positive cells in chronic myeloid leukemia.
    Kimura A; Kawaishi K; Sasaki A; Hyodo H; Oguma N
    Leuk Lymphoma; 1998 Jan; 28(3-4):399-404. PubMed ID: 9517512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell adhesion molecules in cord blood hematopoietic progenitors.
    Timeus F; Crescenzio N; Marranca D; Dall'Aglio M; Fazio L; Di Marco M; Saracco P; Ricotti M; Gabutti V
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S61-2. PubMed ID: 9715892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
    Manz CY; Nissen C; Wodnar-Filipowicz A
    Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery.
    Möhle R; Murea S; Kirsch M; Haas R
    Exp Hematol; 1995 Dec; 23(14):1535-42. PubMed ID: 8542944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development.
    Greenberg AW; Kerr WG; Hammer DA
    Blood; 2000 Jan; 95(2):478-86. PubMed ID: 10627452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
    Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
    J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve.
    Pratt G; Rawstron AC; English AE; Johnson RJ; Jack AS; Morgan GJ; Smith GM
    Br J Haematol; 2001 Sep; 114(4):937-43. PubMed ID: 11564089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle.
    Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P
    Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
    Bhatia R; Wayner EA; McGlave PB; Verfaillie CM
    J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.